CoChat

Review: Problems associated with long-term treatment with selective serotonin reuptake inhibitors

Moret, C., Isaac, M., Briley, M. · 2009 · Journal of Psychopharmacology

The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.

Abstract

Although the selective serotonin reuptake inhibitors (SSRIs), which are now widely used as a first-line treatment for depression and many other psychiatric conditions, are generally well tolerated, they are not devoid of side effects. Most short-term treatment-related side effects of SSRIs are transient and disappear after a few days or weeks. However, following long-term treatment with the SSRIs, some serious adverse events may occur. Some of them can be difficult to recognise because they can resemble residual symptoms of depression. The most serious can be life threatening. They all have a negative influence on the patient's quality of life and are frequently a prime reason for a lack of long-term compliance with the associated increased risk of recurrence of a depressive episode. This article is an overview of the more common adverse events, which are seen with non-acute treatment with the SSRIs.

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881108093582

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 87 references

Research works printed but not linked: 13

  1. George, MS, 1992, J Clin Psychiatry, 53, 379
  2. Guay, D., 2000, Consult Pharm, 15, 160
  3. Gumnick, JF, 2000, J Clin Psychiatry, 61, 5
  4. Hoehn-Saric, R., 1991, J Clin Psychiatry, 52, 131
  5. Kelsey, JE ( 2001) Mood disorders. In: Rakel, RE, Bope, ET (eds), Conn’s Current Therapy. Philadelphia: WB Saunders Company, pp. 1147-1154.
  6. Lerner, UH, 2005, Lakartidningen, 102, 2746
  7. Lieberman, JA, 2003, Prim Care Companion J Clin Psychiatry, 5, 6
  8. 10.3109/hrp.7.2.69 · doi:10.3109/hrp.7.2.69 · Paper page
  9. Odar-Cederlöf, I., 2006, Lakartidningen, 103, 1112
  10. Richelson, E., 1996, J Clin Psychiatry, 16, 1S
  11. Rothschild, AJ, 1991, J Clin Psychiatry, 52, 491
  12. Ryan, D., 2005, Can Fam Physician, 51, 1087
  13. 10.1016/s0140-6736(05)70271-3 · doi:10.1016/s0140-6736(05)70271-3 · Paper page

Cited by

See all 141

Metadata

Authors
Moret, C., Isaac, M., & Briley, M.
Affiliations
  • NeuroBiz Consulting & Communication, Castres, France,
  • South London and Maudsley NHS Foundation Trust (GB)
  • NeuroBiz Consulting & Communication, Castres, France
Corresponding author
Moret, C.
Venue
Journal of Psychopharmacology
Published
2008-07-17
Volume
23
Issue
8
Pages
967-974
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2006895116
Cited by
135
References
87
Citations by year
2026: 6 · 2025: 6 · 2024: 13 · 2023: 14 · 2022: 12 · 2021: 10 · 2020: 11 · 2019: 6 · 2018: 10 · 2017: 3 · 2016: 3 · 2015: 6 · 2014: 8 · 2013: 7 · 2012: 10
FWCI
0.36
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords
selective serotonin reuptake inhibitors, long-term treatment, adverse drug reactions, antidepressant side effects, depression, medication adherence, depression recurrence, quality of life
MeSH terms
Adult, Child, Female, Fetus, Gastrointestinal Hemorrhage, Humans, Hyponatremia, Infant, Newborn, Neonatal Abstinence Syndrome, Pregnancy, Sexual Behavior, Sleep Wake Disorders, Suicide, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Review: Problems associated with long-term treatment with selective serotonin reuptake inhibitors. https://app.cochat.ai/papers/10.1177/0269881108093582
The paper
Moret, C., Isaac, M., & Briley, M. (2009). Review: Problems associated with long-term treatment with selective serotonin reuptake inhibitors. Journal of Psychopharmacology. https://doi.org/10.1177/0269881108093582

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.